Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Meunier

Showing results (41-50 of 205) with videos related to

Pageof 21
Sort By:
Acta Clinica Belgica|January 1, 1976
[Klebsiella resistant to gentamycin in a hospital milieu]F Meunier-Carpentier, J Klastersky
The Journal of Antimicrobial Chemotherapy|January 1, 1982
Experience of mezlocillin in immunocompromised patientsF Meunier-Carpentier, J Klastersky
Presse Medicale (Paris, France : 1983)|February 23, 1999
[General or locoregional anesthesia: which to choose for a patient at risk?]J F Meunier, K Samii
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
EORTC scientific strategy meeting 25-26 March 1999F Meunier, J C Horiot
Journal of Clinical Microbiology|January 1, 1981
Candida antigenemia, as detected by passive hemagglutination inhibition, in patients with disseminated candidiasis or Candida colonizationF Meunier-Carpentier, D Armstrong
The Journal of Antimicrobial Chemotherapy|November 1, 1989
In-vitro effects of cilofungin (LY121019), amphotericin B and amphotericin B-deoxycholate on human polymorphonuclear leucocytesP Van der Auwera, F Meunier
Reviews of Infectious Diseases|March 1, 1990
Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazoleF Meunier, M Aoun, M Gerard
Pathologie-Biologie|April 1, 1990
[Antibiotherapy in the patient with granulocytopenic cancer]P Van Der Auwera, F Meunier
European Journal of Cancer. Part B, Oral Oncology|May 1, 1994
Value of antifungal prophylaxis with antifungal drugs against oropharyngeal candidiasis in cancer patientsF Meunier, M Paesmans, P Autier
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
40 years of the EORTC: the evolution towards a unique network to develop new standards of cancer care. European Organisation for Research and Treatment of CancerF Meunier, A T van Oosterom
Pageof 21

Showing results (41-50 of 205) with videos related to

Sort By:
Pageof 21
Acta Clinica Belgica|January 1, 1976
[Klebsiella resistant to gentamycin in a hospital milieu]F Meunier-Carpentier, J Klastersky
The Journal of Antimicrobial Chemotherapy|January 1, 1982
Experience of mezlocillin in immunocompromised patientsF Meunier-Carpentier, J Klastersky
Presse Medicale (Paris, France : 1983)|February 23, 1999
[General or locoregional anesthesia: which to choose for a patient at risk?]J F Meunier, K Samii
European Journal of Cancer (Oxford, England : 1990)|February 16, 2000
EORTC scientific strategy meeting 25-26 March 1999F Meunier, J C Horiot
Journal of Clinical Microbiology|January 1, 1981
Candida antigenemia, as detected by passive hemagglutination inhibition, in patients with disseminated candidiasis or Candida colonizationF Meunier-Carpentier, D Armstrong
The Journal of Antimicrobial Chemotherapy|November 1, 1989
In-vitro effects of cilofungin (LY121019), amphotericin B and amphotericin B-deoxycholate on human polymorphonuclear leucocytesP Van der Auwera, F Meunier
Reviews of Infectious Diseases|March 1, 1990
Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazoleF Meunier, M Aoun, M Gerard
Pathologie-Biologie|April 1, 1990
[Antibiotherapy in the patient with granulocytopenic cancer]P Van Der Auwera, F Meunier
European Journal of Cancer. Part B, Oral Oncology|May 1, 1994
Value of antifungal prophylaxis with antifungal drugs against oropharyngeal candidiasis in cancer patientsF Meunier, M Paesmans, P Autier
European Journal of Cancer (Oxford, England : 1990)|February 23, 2002
40 years of the EORTC: the evolution towards a unique network to develop new standards of cancer care. European Organisation for Research and Treatment of CancerF Meunier, A T van Oosterom
Pageof 21